Key Insights

Highlights

Treatment Research

6 treatments under study, led by Standard Adult Donor Red Blood Cells

Research Leaders

9 sponsors active, led by Hospital Clinic of Barcelona

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Not Yet Recruiting3
Recruiting1

Clinical Trials (4)

Research Network

Common Treatments

  • Standard Adult Donor Red Blood Cells1
  • Higher 90 Starting Rh In The Incubator With Humidity Supplementation Stopped At Day 281
  • Higher 90 Starting Rh In The Incubator With Humidity Supplementation Stopped At Day 101
  • Cord Blood Red Blood Cells1
  • Lower 70 Starting Rh In The Incubator With Humidity Supplementation Stopped At Day 281

Active Sponsors

  • Hospital Clinic of Barcelona1
  • The First Hospital of Jilin University1
  • Parc Taulí Hospital Universitari1
  • The University of Texas Health Science Center, Houston1
  • Hospital Sant Joan de Deu1

Top Investigators

Related Conditions

  • Umbilical Cord Blood1
  • Pain1
  • Fetal Hemoglobin1
  • Bronchopulmonary Dysplasia Bpd1
  • Anemia Neonatal1

Activity Timeline